Viewing Study NCT05245656


Ignite Creation Date: 2025-12-24 @ 11:34 PM
Ignite Modification Date: 2025-12-25 @ 9:23 PM
Study NCT ID: NCT05245656
Status: RECRUITING
Last Update Posted: 2024-08-06
First Post: 2022-02-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study Comparing Rituximab/Bendamustin(RB) Alternating With Rituximab/Bendamustin/Cytarabin(RBAC) With RB Therapy in Elderly Patients With Mentle Cell Lymphoma
Sponsor: Kim, Seok Jin
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module